高级检索
    宋勇, 张潮. Pembrolizumab与多西紫杉醇在晚期经治PD-L1阳性非小细胞肺癌患者中的疗效比较[J]. 循证医学, 2017, 17(1): 50-54. DOI: 10.12019/j.issn.1671-5144.2017.01.014
    引用本文: 宋勇, 张潮. Pembrolizumab与多西紫杉醇在晚期经治PD-L1阳性非小细胞肺癌患者中的疗效比较[J]. 循证医学, 2017, 17(1): 50-54. DOI: 10.12019/j.issn.1671-5144.2017.01.014
    shu
    SONG Yong, ZHANG Chao. Compare the Curative Effect of Pembrolizumab and Docetaxel for Previously Treated PD-L1-Positive Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(1): 50-54. DOI: 10.12019/j.issn.1671-5144.2017.01.014
    Citation: SONG Yong, ZHANG Chao. Compare the Curative Effect of Pembrolizumab and Docetaxel for Previously Treated PD-L1-Positive Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(1): 50-54. DOI: 10.12019/j.issn.1671-5144.2017.01.014
    shu

    Pembrolizumab与多西紫杉醇在晚期经治PD-L1阳性非小细胞肺癌患者中的疗效比较

    Compare the Curative Effect of Pembrolizumab and Docetaxel for Previously Treated PD-L1-Positive Advanced Non-Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(9)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回